Cargando…

Autoantibodies Specific to ERα are Involved in Tamoxifen Resistance in Hormone Receptor Positive Breast Cancer

Tamoxifen resistance is a major hurdle in the treatment of estrogen receptor (ER)-positive breast cancer. The mechanisms of tamoxifen resistance are not fully understood although several underlying molecular events have been suggested. Recently, we identified autoantibodies reacting with membrane-as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maselli, Angela, Parlato, Stefania, Puglisi, Rossella, Raggi, Carla, Spada, Massimo, Macchia, Daniele, Pontecorvi, Giada, Iessi, Elisabetta, Pagano, Maria Teresa, Cirulli, Francesca, Gabriele, Lucia, Carè, Alessandra, Vici, Patrizia, Pizzuti, Laura, Barba, Maddalena, Matarrese, Paola, Pierdominici, Marina, Ortona, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678306/ https://www.ncbi.nlm.nih.gov/pubmed/31331091 http://dx.doi.org/10.3390/cells8070750

Ejemplares similares

Autoantibodies specific to estrogen receptor alpha act as estrogen agonists and their levels correlate with breast cancer cell proliferation
por: Maselli, Angela, et al.
Publicado: (2015)

The Sex-Related Interplay between TME and Cancer: On the Critical Role of Estrogen, MicroRNAs and Autophagy
por: Matarrese, Paola, et al.
Publicado: (2021)

Different Susceptibilities of Human Melanoma Cell Lines to G2/M Blockage and Cell Death Activation in Response to the Estrogen Receptor β agonist LY500307
por: Pontecorvi, Giada, et al.
Publicado: (2022)

Chronic Isolation Stress Affects Central Neuroendocrine Signaling Leading to a Metabolically Active Microenvironment in a Mouse Model of Breast Cancer
por: Berry, Alessandra, et al.
Publicado: (2021)

Biomarkers for Diagnosis, Prognosis and Response to Immunotherapy in Melanoma
por: Puglisi, Rossella, et al.
Publicado: (2021)

Sex and Gender Disparities in Melanoma
por: Bellenghi, Maria, et al.
Publicado: (2020)

SCD5 restored expression favors differentiation and epithelial-mesenchymal reversion in advanced melanoma
por: Puglisi, Rossella, et al.
Publicado: (2018)

Cell death-based treatments of melanoma:conventional treatments and new therapeutic strategies
por: Mattia, Gianfranco, et al.
Publicado: (2018)

Non-genomic Effects of Estrogen on Cell Homeostasis and Remodeling With Special Focus on Cardiac Ischemia/Reperfusion Injury
por: Puglisi, Rossella, et al.
Publicado: (2019)

Autoantibodies to Estrogen Receptor α in Systemic Sclerosis (SSc) as Pathogenetic Determinants and Markers of Progression
por: Giovannetti, Antonello, et al.
Publicado: (2013)

Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitors
por: Vici, Patrizia, et al.
Publicado: (2020)

On exosome functional role in cancer: miR-494 complex regulation in melanoma cells and corresponding exosomes
por: Bellenghi, Maria, et al.
Publicado: (2019)

Long-Term Safety and Real-World Effectiveness of Trastuzumab in Breast Cancer
por: Mazzotta, Marco, et al.
Publicado: (2019)

Case report: 5-year progression free survival and complete liver response in a patient with metastatic breast cancer treated with everolimus plus exemestane
por: Krasniqi, Eriseld, et al.
Publicado: (2020)

Burnout of health care providers during the COVID-19 pandemic: Focus on Medical Oncologists
por: Vici, Patrizia, et al.
Publicado: (2021)

Role of Cholesterol and Lipid Rafts in Cancer Signaling: A Promising Therapeutic Opportunity?
por: Vona, Rosa, et al.
Publicado: (2021)

A Sex Perspective in Neurodegenerative Diseases: microRNAs as Possible Peripheral Biomarkers
por: Piscopo, Paola, et al.
Publicado: (2021)

Highly durable response to capecitabine in patient with metastatic estrogen receptor positive breast cancer: A case report
por: Barchiesi, Giacomo, et al.
Publicado: (2019)

The role of vitamin D in autoimmune diseases: could sex make the difference?
por: Dupuis, Maria Luisa, et al.
Publicado: (2021)

Targeting the Interplay between Cancer Metabolic Reprogramming and Cell Death Pathways as a Viable Therapeutic Path
por: Iessi, Elisabetta, et al.
Publicado: (2021)

Human Monocyte-Derived Dendritic Cells Are the Pharmacological Target of the Immunosuppressant Flavonoid Silibinin
por: Pagano, Maria Teresa, et al.
Publicado: (2022)

Estrogen receptor β ligation inhibits Hodgkin lymphoma growth by inducing autophagy
por: Pierdominici, Marina, et al.
Publicado: (2016)

Cancer patients and coronavirus disease 2019: evidence in context
por: Barba, Maddalena, et al.
Publicado: (2020)

Editorial: Sex Hormones and Gender Differences in Immune Responses
por: Ortona, Elena, et al.
Publicado: (2019)

FOLFIRI as a second-line therapy in patients with docetaxel-pretreated gastric cancer: a historical cohort
por: Maugeri-Saccà, Marcello, et al.
Publicado: (2013)

Tamoxifen Action in ER-Negative Breast Cancer
por: Manna, Subrata, et al.
Publicado: (2016)

Anti-Inflammatory Effects of 1,25(OH)2D/Calcitriol in T Cell Immunity: Does Sex Make a Difference?
por: Peruzzu, Daniela, et al.
Publicado: (2022)

Efficacy of chemotherapy in metastatic male breast cancer patients: a retrospective study
por: Di Lauro, Luigi, et al.
Publicado: (2015)

COVID‐19 risk in breast cancer patients receiving CDK4/6 inhibitors: literature data and a monocentric experience
por: Barba, Maddalena, et al.
Publicado: (2021)

Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) in Luminal Breast Cancer: A Retrospective Analysis in the Neoadjuvant Setting
por: Grassadonia, Antonino, et al.
Publicado: (2021)

Coronavirus Interplay With Lipid Rafts and Autophagy Unveils Promising Therapeutic Targets
por: Fecchi, Katia, et al.
Publicado: (2020)

Tamoxifen-Independent Recombination in the RIP-CreER Mouse
por: Liu, Yanmei, et al.
Publicado: (2010)

Oral Administration of Fermented Papaya (FPP(®)) Controls the Growth of a Murine Melanoma through the In Vivo Induction of a Natural Antioxidant Response
por: Logozzi, Mariantonia, et al.
Publicado: (2019)

Stratification of Tamoxifen Synergistic Combinations for the Treatment of ER+ Breast Cancer
por: Zboril, Emily K., et al.
Publicado: (2023)

Vitamin D Supplementation and Breast Cancer Prevention: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Sperati, Francesca, et al.
Publicado: (2013)

Emerging Biological Treatments for Uterine Cervical Carcinoma
por: Vici, Patrizia, et al.
Publicado: (2014)

Role of gonadotropin-releasing hormone analogues in metastatic male breast cancer: results from a pooled analysis
por: Di Lauro, Luigi, et al.
Publicado: (2015)

Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical Trials
por: Grassadonia, Antonino, et al.
Publicado: (2018)

Neutrophil extracellular traps in cancer: not only catching microbes
por: Ronchetti, Livia, et al.
Publicado: (2021)

Tamoxifen may prevent both ER+ and ER- breast cancers and select for ER- carcinogenesis: an alternative hypothesis
por: Esserman, Laura J, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_2nun9htonr4nre9loujuap59he